26548 DaxibotulinumtoxinA for injection (DAXI) demonstrates consistent efficacy, duration, and safety in females independent of age: Subgroup analysis from a large, phase 3 program

Saved in:
Bibliographic Details
Published in:Journal of the American Academy of Dermatology 2021-09, Vol.85 (3), p.AB105-AB105
Main Authors: Ablon, Glynis, Shamban, Ava, Weinkle, Susan, Weinkle, Susan H., Brown, Jessica, Liu, Yan
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0190-9622
1097-6787
DOI:10.1016/j.jaad.2021.06.438